Please provide your email address to receive an email when new articles are posted on . “This study is unique in that it included only patients with advanced glaucoma and focused on the identification ...

Faster thinning of cpRNFL and mGCIPL is associated with visual field progression in glaucoma, with rates of –1.02 and –1.04 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Black patients had a higher risk for developing advanced ...

Twenty-four-week data from the Ph1/2a trial in glaucoma patients reveals PER-001 to be well-tolerated. Proof of concept is established with both strong functional and structural outcomes Glaucoma ...

As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...

The COVID-19 pandemic made it clear that we need novel solutions for monitoring patients with chronic diseases such as glaucoma. One area that is particularly ripe for disruption is perimetry testing.

Glaucoma is a blinding disease caused by damage to the optic nerve, leading to permanent vision loss. The main risk factor is ...

Glaucoma damages the optic nerve and can lead to blindness if you do not treat the condition. You can get regular eye exams ...

Glaucoma can begin silently, even in people in their 20s and 30s. Doctors warn that early signs are often mistaken for eye ...